David Mooney | Knight Campus Distinguished Lecture Series, November 6, 2024

In his talk, David Mooney will discuss how T cell-based therapies are revolutionizing the treatment of some types of cancer, but currently suffer from a number of limitations. To address these challenges, researchers are developing biomaterials capable of concentrating, interrogating, and manipulating stem and immune cells ex vivo and in the body by controlling, in space and time, the interaction of the cells with various immunomodulatory cues. Therapeutic cancer vaccines and the development of artificial antigen presenting cells for the manufacturing and in vivo boosting of adaptive T cell-based therapies will be highlighted.
David Mooney is the Robert Pinkas Family Professor of Bioengineering and a core faculty member in Harvard University's School of Engineering and Applied Sciences and the Wyss Institute for Biologically Inspired Engineering. He is also a member of the Knight Campus External Advisory Board, as well as several national academies, and has won numerous awards for his research and his mentorship/teaching. To learn more about David Mooney, view his bio on the External Advisory Board web page.
The Knight Campus Distinguished Lecture Series is an annual event designed to bring nationally and internationally recognized science, technology and engineering leaders to the University of Oregon community to give their perspective on the future of their fields.